Thyro-CPR: Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation

Sponsor
Ruhr University of Bochum (Other)
Overall Status
Recruiting
CT.gov ID
NCT04392258
Collaborator
(none)
200
1
20
10

Study Details

Study Description

Brief Summary

Time-limited adaptive responses of thyroid function are common in the critically ill. About 70% of all patients treated on intensive care units develop a so-called non-thyroidal illness syndrome (NTIS) or TACITUS (thyroid allostasis in critical illness, tumours, uraemia and starvation), which is marked by low serum concentrations of the thyroid hormone T3 and other adaptive reactions of thyroid homeostasis. Occasionally, temporarily elevated concentrations of thyrotropin (TSH) and peripheral thyroid hormones are to be observed, especially after cardiopulmonary resuscitation (CPR). However, the available evidence is limited, although abnormal concentrations of thyroid hormones after CPR have occasionally been reported.

Aim of the planned study is to investigate the thyrotropic (i.e. thyroid-controlling) partial function of the anterior pituitary lobe immediately after CPR. It is intended to evaluate statistical measures of TSH concentration and peripheral thyroid hormones in de-identified datasets (protocol A). Additionally, a prospective sub-study (protocol B) aims at a more precise description of pituitary and thyroid responses by means of serial investigations in routine serum samples, both immediately after CPR and during the course of ongoing treatment. This includes the evaluation of additional possible predictors, too.

Primary endpoint of the study is changed TSH concentration immediately after CPR compared to the TSH value 24 hours later. Secondary endpoint is the relation between thyroid-controlling pituitary function and mortality.

A high proportion of patients undergoing CPR will eventually receive iodinated radiocontrast media (e.g. for computed tomography or coronary angiography). This is one of the reasons why early identifying subjects at high risk for possible iodine-induced thyrotoxicosis is important. Increased oxygen consumption of the heart in hyperthyroidism is one of the reasons for high mortality in thyrotoxicosis. Therefore, accurate diagnosis of alterations in the hypothalamus-pituitary-thyroid (HPT) axis is of paramount importance.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: TSH determination
  • Diagnostic Test: FT4 determination
  • Diagnostic Test: FT3 determination
  • Diagnostic Test: SPINA-GT
  • Diagnostic Test: SPINA-GD

Detailed Description

Transient allostatic responses of thyroid function are common in the critically ill. About 70% of all patients treated on intensive care units develop a so-called non-thyroidal illness syndrome (NTIS) or TACITUS (thyroid allostasis in critical illness, tumours, uraemia and starvation), which is marked by low serum concentrations of the thyroid hormone T3 and other adaptive reactions of thyroid homeostasis. Occasionally, temporarily elevated concentrations of thyrotropin (TSH) and peripheral thyroid hormones are to be observed, especially after cardio-pulmonary resuscitation (CPR). However, the available evidence is limited, although abnormal concentrations of thyroid hormones after CPR have been reported.

Aim of the planned study is to investigate the thyrotropic partial function of the anterior pituitary lobe immediately after CPR. It is intended to evaluate statistical moments of TSH concentration and peripheral thyroid hormones in de-identified datasets (protocol A). Additionally, a prospective substudy (protocol B) aims at a more precise description of pituitary and thyroid responses by means of serial investigations in routine serum samples, both immediately after CPR and during the course of ongoing in-patient treatment. This also includes the evaluation of additional possible predictors.

Primary endpoint of the study are changed TSH concentrations immediately after CPR compared to the value 24 hours later. Secondary endpoint is the relation between thyrotropic pituitary function and mortality.

A high proportion of patients undergoing CPR will eventually receive iodinated radiocontrast media (e.g. for computed tomography or coronary angiography). This is one of the reasons why early identifying subjects at high risk for possible iodine-induced thyrotoxicosis is important. Increases oxygen consumption of myocardial tissue in hyperthyroidism is one of the reasons for high mortality in thyrotoxicosis. Therefore, accurate diagnosis of alterations in the hypothalamus-pituitary-thyroid (HPT) axis is of paramount importance.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation
Actual Study Start Date :
May 1, 2021
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Status post resuscitation

Patients or dataset that underwent resuscitation

Diagnostic Test: TSH determination
Determination of serum concentration of thyrotropin (TSH)
Other Names:
  • serum thyrotropin determination
  • Diagnostic Test: FT4 determination
    Determination of serum free thyroxine (FT4) concentration
    Other Names:
  • serum free T4 determination
  • Diagnostic Test: FT3 determination
    Determination of serum free triiodothyronine (FT3) concentration
    Other Names:
  • serum free T3 determination
  • Diagnostic Test: SPINA-GT
    Calculation of thyroid's secretory capacity (SPINA-GT)
    Other Names:
  • GT
  • Thyroid's secretory capacity
  • LOINC 82368-2
  • thyroid's incretory capacity
  • Diagnostic Test: SPINA-GD
    Calculation of total deiodinase activity (SPINA-GD)
    Other Names:
  • GD
  • Sum activity of peripheral deiodinases
  • LOINC 82367-4
  • deiodination capacity
  • Outcome Measures

    Primary Outcome Measures

    1. TSH response [three hours]

      Changes in TSH concentration after CPR compared to the value after 24 hours

    Secondary Outcome Measures

    1. Prognosis [Through study completion, an average of 1 year]

      Mortality dependent on pituitary thyrotropic partial function

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Admission after cardiopulmonary resuscitation

    • Minimum age of 18 years

    • Results of TSH and peripheral thyroid hormone concentrations already available or possibility to reorder these investigations in a post-hoc manner if consent has been obtained (i. e. time interval after venipuncture within the storage period of the central laboratory)

    • Inclusion after own consent of the patient after reawakening, via custodian or independent consultant.

    Exclusion Criteria:
    • Missing data on thyroid homeostasis in the first blood specimen (obtained before 3 hours after admission)

    • Traumatic brain injury

    • Persistent hints for thyroid dysfunction, not explained by non-thyroidal illness syndrome (NTIS) / euthyroid sick syndrome (ESS) / thyroid allostasis in critical illness, tumors, uremia and starvation (TACITUS) in consecutive investigations over several days after resuscitation

    • Functionally relevant thyroid or pituitary disorder, as documented in international classification of diseases (ICD) codes.

    • Exposure to radiocontrast agents less than 3 months ago

    • Therapy with amiodarone (currently or during the previous 3 years)

    • Pregnancy

    • Known thyroid disease

    • Consent not obtained within the routine storage period of the central laboratory

    • Post-hoc-exclusion if evidence for true dysfunction the the pituitary or the thyroid became available during the study period.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Medizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum Bochum NRW Germany D-44789

    Sponsors and Collaborators

    • Ruhr University of Bochum

    Investigators

    • Principal Investigator: Johannes W Dietrich, M.D., Bergmannsheil University Hospitals

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    PD Dr. Johannes W. Dietrich, MD, Consultant endocrinologist, Ruhr University of Bochum
    ClinicalTrials.gov Identifier:
    NCT04392258
    Other Study ID Numbers:
    • 19-6678-BR
    • U1111-1251-7468
    • DRKS00021695
    First Posted:
    May 18, 2020
    Last Update Posted:
    Aug 19, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by PD Dr. Johannes W. Dietrich, MD, Consultant endocrinologist, Ruhr University of Bochum
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 19, 2021